57% Reduction in Total Cholesterol from Nyrada’s NYX-PCSK9i In Vivo Study Jan 25, 2021 ASX News Nyrada Inc (ASX:NYR) Send Share Share
Nyrada Successfully Completes Safety Studies Ahead of Phase I Clinical Trial Oct 17, 2024 | Nyrada Inc (ASX:NYR)
Incannex to Issue Loyalty Options to Shareholders Mar 18, 2022 | ASX News, Incannex Healthcare (ASX:IHL)
